Moderna has a plan to revolutionize how certain cancers are treated. We’re about to find out its potential in melanoma.

Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.

More Top Stories News

The 3 questions every AI investor needs to ask right now

Markets are pricing in long-term AI winners. This veteran investor says history proves customers win more than innovators.

Two big reasons Micron and other chip stocks are falling on Thursday

Investors’ recent money moves show a preference for lowering risks over boosting rewards

My partner of 17 years left me his $1 million home. His children are crying foul. Am I obliged to split it with them?

Content sourced from MarketWatch. Not financial advice.